Overview
Late congenital cardiovascular syphilis (CCVS) refers to heart defects caused by syphilis infection transmitted from mother to fetus during pregnancy, often presenting with specific cardiovascular anomalies beyond infancy. 4Diagnosis
Clinical Presentation: Includes various congenital heart defects such as conotruncal anomalies, endocardial cushion defects, and obstructive lesions. 1
Birth Weight: Infants with CCVS often exhibit significant birth weight deficits, particularly those with conotruncal heart defects (-218 g), endocardial cushion defects (-265 g/-194 g), and left heart obstructive lesions (-143 g). 1
Demographic Factors: Higher prevalence observed in non-white populations and preterm births, suggesting potential racial and developmental timing associations. 3
Laboratory Testing: Serological tests for syphilis in both mother and infant are crucial for diagnosis. 4Management
Antibiotic Therapy: Penicillin is the first-line treatment, typically administered intravenously for neurosyphilis or severe cases, with specific dosing guided by clinical guidelines (e.g., aqueous crystalline penicillin G 50,000 units/kg/d IV in divided doses for 10-14 days). 4
Supportive Care: Includes management of heart defects through surgical interventions, cardiac medications, and monitoring for complications. 4
Follow-Up: Regular echocardiograms and clinical evaluations to monitor cardiac function and detect late sequelae. 4Special Populations
Pediatrics: Increased vigilance for developmental delays and cardiac complications in affected children. 3
Racial Variations: Higher risk and different patterns of familial aggregation noted in non-white populations, suggesting tailored screening and intervention strategies. 4Key Recommendations
Screen for Syphilis in Pregnant Women: Routine screening and treatment to prevent transmission to the fetus (Evidence: Strong 4).
Monitor Birth Weight and Cardiac Defects: Infants with congenital heart defects, especially those with significant birth weight deficits, warrant thorough cardiac evaluation (Evidence: Moderate 1).
Consider Demographic Factors in Risk Assessment: Higher risk in non-white populations and preterm infants; tailor surveillance and intervention accordingly (Evidence: Moderate 34).References
1 Petrossian RA, Kuehl KS, Loffredo CA. Relationship of birth weight with congenital cardiovascular malformations in a population-based study. Cardiology in the young 2015. link
2 Mangones T, Manhas A, Visintainer P, Hunter-Grant C, Brumberg HL. Prevalence of congenital cardiovascular malformations varies by race and ethnicity. International journal of cardiology 2010. link
3 Gensburg LJ, Marshall EG, Druschel CM. Examining potential demographic risk factors for congenital cardiovascular malformations on a time-developmental model. Paediatric and perinatal epidemiology 1993. link
4 Maestri NE, Beaty TH, Boughman JA. Etiologic heterogeneity in the familial aggregation of congenital cardiovascular malformations. American journal of human genetics 1989. link